According to Insulet's latest financial reports the company's current revenue (TTM) is $1.69 B. In 2022 the company made a revenue of $1.30 B an increase over the years 2021 revenue that were of $1.09 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.69 B | 30.02% |
2022 | $1.30 B | 18.79% |
2021 | $1.09 B | 21.49% |
2020 | $0.90 B | 22.52% |
2019 | $0.73 B | 30.93% |
2018 | $0.56 B | 21.57% |
2017 | $0.46 B | 26.37% |
2016 | $0.36 B | 30.97% |
2015 | $0.28 B | -2.95% |
2014 | $0.28 B | 16.85% |
2013 | $0.24 B | 16.9% |
2012 | $0.21 B | 38.83% |
2011 | $0.15 B | 57.02% |
2010 | $96.96 M | 46.85% |
2009 | $66.03 M | 83.12% |
2008 | $36.05 M | 169.66% |
2007 | $13.37 M | 242.08% |
2006 | $3.9 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 5,183.07% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $40.10 B | 2,263.38% | ๐บ๐ธ USA |
Medtronic MDT | $32.32 B | 1,804.43% | ๐ฎ๐ช Ireland |
Eli Lilly LLY | $35.93 B | 2,017.26% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | $0.74 B | -55.94% | ๐บ๐ธ USA |
ICU Medical
ICUI | $2.25 B | 33.12% | ๐บ๐ธ USA |
DexCom DXCM | $3.80 B | 124.02% | ๐บ๐ธ USA |